Related references
Note: Only part of the references are listed.Circulating galectin-3 on admission and prognosis in acute heart failure patients: a meta-analysis
Hongsen Chen et al.
HEART FAILURE REVIEWS (2020)
The predictive value of serum galectin 3 for abdominal aortic calcification in maintenance hemodialysis patients: A prospective cohort study
Zhiyu Wang et al.
HEMODIALYSIS INTERNATIONAL (2020)
A Real-World Experience of Clinical, Biochemical and Genetic Assessment of Patients with Homozygous Familial Hypercholesterolemia
Maria Donata Di Taranto et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Galectin-3 as a Next-Generation Biomarker for Detecting Early Stage of Various Diseases
Akira Hara et al.
BIOMOLECULES (2020)
Galectin-3 Is a Potential Mediator for Atherosclerosis
Ziyu Gao et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2020)
Plasma Galectin-3 predicts deleterious vascular dysfunction affecting post-myocardial infarction patients: An explanatory study
Olivier Huttin et al.
PLOS ONE (2020)
Soluble ST2 and Soluble Markers of Fibrosis: Emerging Roles for Prognosis and Guiding Therapy
Justin Sharim et al.
CURRENT CARDIOLOGY REPORTS (2020)
Galectin-3 is Associated with Cardiovascular Events in Post-Acute Coronary Syndrome Patients with Type-2 Diabetes
Ana Lorenzo-Almoros et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Galectin-3 as the Prognostic Factor of Adverse Cardiovascular Events in Long-Term Follow up in Patients after Myocardial Infarction-A Pilot Study
Przemyslaw Swiecki et al.
JOURNAL OF CLINICAL MEDICINE (2020)
Galectin-3 Identifies a Subset of Macrophages With a Potential Beneficial Role in Atherosclerosis
Karina Di Gregoli et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2020)
Fibrosis and Inflammatory Markers and Long-Term Risk of Peripheral Artery Disease The ARIC Study
Ning Ding et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2020)
Association of Cardiac Biomarkers With the Kansas City Cardiomyopathy Questionnaire in Patients With Chronic Kidney Disease Without Heart Failure
Sri Lekha Tummalapalli et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
Levels and Change in Galectin-3 and Association With Cardiovascular Events: The ARIC Study
David Aguilar et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2020)
Innate Immune Response to Tick-Borne Pathogens: Cellular and Molecular Mechanisms Induced in the Hosts
Alessandra Torina et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Relation of Biomarkers of Cardiac Injury, Stress, and Fibrosis With Cardiac Mechanics in Patients ≥ 65 Years of Age
John S. Gottdiener et al.
AMERICAN JOURNAL OF CARDIOLOGY (2020)
The Role of Biomarkers in Cardio-Oncology
Kajaluxy Ananthan et al.
JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH (2020)
Sex-Specific Associations of Cardiovascular Risk Factors and Biomarkers With Incident Heart Failure
Navin Suthahar et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Immune Response to Tick-Borne Hemoparasites: Host Adaptive Immune Response Mechanisms as Potential Targets for Therapies and Vaccines
Alessandra Torina et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Cardiac biomarkers of heart failure in chronic kidney disease
Xiaorong Han et al.
CLINICA CHIMICA ACTA (2020)
Galectin-3 knock down inhibits cardiac ischemia-reperfusion injury through interacting with bcl-2 and modulating cell apoptosis
Meiqi Zhang et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2020)
Plasma Galectin-3 and Sonographic Measures of Carotid Atherosclerosis in the Atherosclerosis Risk in Communities Study
Abayomi Oyenuga et al.
ANGIOLOGY (2019)
Galectin-3 Levels and Outcomes After Myocardial Infarction A Population-Based Study
Rabea Asleh et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Negative Risk Markers for Cardiovascular Events in the Elderly
Martin Bodtker Mortensen et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Myocardial Injury After Ischemia/Reperfusion Is Attenuated By Pharmacological Galectin-3 Inhibition
Jaime Ibarrola et al.
SCIENTIFIC REPORTS (2019)
RAGE/galectin-3 yields intraplaque calcification transformation via sortilin
Zhen Sun et al.
ACTA DIABETOLOGICA (2019)
Pleiotropic Effects of Modified Citrus Pectin
Isaac Eliaz et al.
NUTRIENTS (2019)
Novel biomarkers of cardiovascular disease: Applications in clinical practice
Magnus Nakrem Lyngbakken et al.
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2019)
Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy
Rui Dong et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2018)
Circulating biomarkers for cardiovascular diseases: the beats never stop
Lei Xi et al.
ACTA PHARMACOLOGICA SINICA (2018)
Ticagrelor attenuates myocardial ischaemia-reperfusion injury possibly through downregulating galectin-3 expression in the infarct area of rats
Xiaogang Liu et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2018)
Galectin-3 in Atrial Fibrillation: Mechanisms and Therapeutic Implications
Nicolas Clementy et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Galectin-3: One Molecule for an Alphabet of Diseases, from A to Z
Salvatore Sciacchitano et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Galectins as Molecular Targets for Therapeutic Intervention
Ruud P. M. Dings et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Mechanisms responsible for increased circulating levels of galectin-3 in cardiomyopathy and heart failure
My-Nhan Nguyen et al.
SCIENTIFIC REPORTS (2018)
Galectin-3 Activation and Inhibition in Heart Failure and Cardiovascular Disease: An Update
Navin Suthahar et al.
THERANOSTICS (2018)
Galectin-3 in Heart Failure An Update of the Last 3 Years
Carolin Gehlken et al.
HEART FAILURE CLINICS (2018)
Galectin-3 deficiency enhances type 2 immune cell-mediated myocarditis in mice
Marina Miletic Kovacevic et al.
IMMUNOLOGIC RESEARCH (2018)
Galectin-3 level predicts response to ablation and outcomes in patients with persistent atrial fibrillation and systolic heart failure
Nicolas Clementy et al.
PLOS ONE (2018)
Longitudinal Change in Galectin-3 and Incident Cardiovascular Outcomes
Anahita Ghorbani et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Variability of biomarkers in patients with chronic heart failure and healthy controls
Wouter C. Meijers et al.
EUROPEAN JOURNAL OF HEART FAILURE (2017)
Galectin-3-null mice display defective neutrophil clearance during acute inflammation
Rachael D. Wright et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2017)
ANMCO/ELAS/SIBioC Consensus Document: biomarkers in heart failure
Nadia Aspromonte et al.
EUROPEAN HEART JOURNAL SUPPLEMENTS (2017)
A multimarker multi-time point-based risk stratification strategy in acute heart failure: results from the RELAX-AHF trial
Biniyam G. Demissei et al.
EUROPEAN JOURNAL OF HEART FAILURE (2017)
New developments in the pharmacotherapeutic management of heart failure in elderly patients: concerns and considerations
Elles M. Screever et al.
EXPERT OPINION ON PHARMACOTHERAPY (2017)
Galectin-3 in Peripheral Artery Disease. Relationships with Markers of Oxidative Stress and Inflammation
Isabel Fort-Gallifa et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Modified citrus pectin inhibits galectin-3 function to reduce atherosclerotic lesions in apoE-deficient mice
Yonggang Lu et al.
MOLECULAR MEDICINE REPORTS (2017)
Serum Galectin-3 level, not Galectin-1, is associated with the clinical feature and outcome in patients with acute ischemic stroke
Han Dong et al.
ONCOTARGET (2017)
Causative mutations and premature cardiovascular disease in patients with heterozygous familial hypercholesterolaemia
Paolo Rubba et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2017)
Serum levels of galectin-1, galectin-3, and galectin-9 are associated with large artery atherosclerotic stroke
Xin-Wei He et al.
SCIENTIFIC REPORTS (2017)
Exosomes-Based Biomarkers for the Prognosis of Cardiovascular Diseases
Yihua Bei et al.
EXOSOMES IN CARDIOVASCULAR DISEASES: BIOMARKERS, PATHOLOGICAL AND THERAPEUTIC EFFECTS (2017)
Establishing the upper reference limit of Galectin-3 in healthy blood donors
Luisa Agnello et al.
BIOCHEMIA MEDICA (2017)
Familial hypercholesterolemia: The Italian Atherosclerosis Society Network (LIPIGEN)
Maurizio Averna et al.
ATHEROSCLEROSIS SUPPLEMENTS (2017)
Galectin-3 in acute coronary syndrome
Luisa Agnello et al.
CLINICAL BIOCHEMISTRY (2017)
Potential novel biomarkers of cardiovascular dysfunction and disease: cardiotrophin-1, adipokines and galectin-3
Simona Hogas et al.
ARCHIVES OF MEDICAL SCIENCE (2017)
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
Clyde W. Yancy et al.
CIRCULATION (2017)
Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure A Scientific Statement From the American Heart Association
Sheryl L. Chow et al.
CIRCULATION (2017)
Meta-Analysis of the Usefulness of Plasma Galectin-3 to Predict the Risk of Mortality in Patients With Heart Failure and in the General Population
Tasnim F. Imran et al.
AMERICAN JOURNAL OF CARDIOLOGY (2017)
Circulating Noncoding RNAs as Biomarkers of Cardiovascular Disease and Injury
Janika Viereck et al.
CIRCULATION RESEARCH (2017)
Lipoprotein apheresis reduces circulating galectin-3 in humans
Isaac Eliaz et al.
JOURNAL OF CLINICAL APHERESIS (2016)
Predictive value of Galectin-3 for the occurrence of coronary artery disease and prognosis after myocardial infarction and its association with carotid IMT values in these patients: A mid-term prospective cohort study
Anna Lisowska et al.
ATHEROSCLEROSIS (2016)
Multitasking Human Lectin Galectin-3 Interacts with Sulfated Glycosaminoglycans and Chondroitin Sulfate Proteoglycans
Melanie L. Talaga et al.
BIOCHEMISTRY (2016)
High Plasma Levels of Galectin-3 Are Associated with Increased Risk for Stroke after Carotid Endarterectomy
Andreas Edsfeldt et al.
CEREBROVASCULAR DISEASES (2016)
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Piotr Ponikowski et al.
EUROPEAN HEART JOURNAL (2016)
Inhibition of Galectin-3 Pathway Prevents Isoproterenol-Induced Left Ventricular Dysfunction and Fibrosis in Mice
Giuseppe Vergaro et al.
HYPERTENSION (2016)
Inflammatory Biomarkers and Atherosclerosis
Takeshi Soeki et al.
INTERNATIONAL HEART JOURNAL (2016)
Genetic Variants in the Vicinity of LGALS-3 Gene and LGALS-3 mRNA Expression in Advanced Carotid Atherosclerosis: An Exploratory Study
Ana Djordjevic et al.
JOURNAL OF CLINICAL LABORATORY ANALYSIS (2016)
Is galectin-3 a biomarker, a player-or both-in the presence of coronary atherosclerosis?
Gokhan Aksan et al.
JOURNAL OF INVESTIGATIVE MEDICINE (2016)
Extracellular galectin-3 counteracts adhesion and exhibits chemoattraction in Helicobacter pylori-infected gastric cancer cells
Vinod Vijay Subhash et al.
MICROBIOLOGY-SGM (2016)
New Regulatory Roles of Galectin-3 in High-Affinity IgE Receptor Signaling
Monika Bambouskova et al.
MOLECULAR AND CELLULAR BIOLOGY (2016)
The emerging role of galectins in cardiovascular disease
Nina W. van der Hoeven et al.
VASCULAR PHARMACOLOGY (2016)
Inflammatory markers and extent and progression of early atherosclerosis: Meta-analysis of individual-participant-data from 20 prospective studies of the PROG-IMT collaboration
Peter Willeit et al.
EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2016)
Strategies Used by Bacteria to Grow in Macrophages
Gabriel Mitchell et al.
MICROBIOLOGY SPECTRUM (2016)
The Role of Galectin-3 in the Kidneys
Szu-Chia Chen et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Objectives and methodology of Romanian SEPHAR II Survey. Project for comparing the prevalence and control of cardiovascular risk factors in two East-European countries: Romania and Poland
Maria Dorobantu et al.
ARCHIVES OF MEDICAL SCIENCE (2015)
Galectin-3 Predicts Long-Term Cardiovascular Death in High-Risk Patients With Coronary Artery Disease
Giuseppe Maiolino et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)
The dark and bright side of atherosclerotic calcification
Giuseppe Pugliese et al.
ATHEROSCLEROSIS (2015)
Evaluating the Atrial Myopathy Underlying Atrial Fibrillation Identifying the Arrhythmogenic and Thrombogenic Substrate
Jeffrey J. Goldberger et al.
CIRCULATION (2015)
Galectin-3, Carotid Plaque Vulnerability, and Potential Effects of Statin Therapy
N. P. E. Kadoglou et al.
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY (2015)
The galectin lattice at a glance
Ivan R. Nabi et al.
JOURNAL OF CELL SCIENCE (2015)
Association of USF1 and APOA5 polymorphisms with familial combined hyperlipidemia in an Italian population
Maria Donata Di Taranto et al.
MOLECULAR AND CELLULAR PROBES (2015)
Markers of preclinical atherosclerosis and their clinical relevance
Pavel Poredos et al.
VASA-EUROPEAN JOURNAL OF VASCULAR MEDICINE (2015)
Mineralocorticoid Receptor Antagonists Modulate Galectin-3 and Interleukin-33/ST2 Signaling in Left Ventricular Systolic Dysfunction After Acute Myocardial Infarction
Antonio Lax et al.
JACC-HEART FAILURE (2015)
The Impact of Galectin-3 Inhibition on Aldosterone-Induced Cardiac and Renal Injuries
Laurent Calvier et al.
JACC-HEART FAILURE (2015)
The role of galectin-3 and galectin-3-binding protein in venous thrombosis
Elise P. DeRoo et al.
BLOOD (2015)
Elevated plasma galectin-3 is associated with near-term rehospitalization in heart failure: A pooled analysis of 3 clinical trials
Wouter C. Meijers et al.
AMERICAN HEART JOURNAL (2014)
The pathogenesis of cardiac fibrosis
Ping Kong et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2014)
Galectin-3 expression in cardiac remodeling after myocardial infarction
J. Sanchez-Mas et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
Nuclear transport of galectin-3 and its therapeutic implications
Tatsuyoshi Funasaka et al.
SEMINARS IN CANCER BIOLOGY (2014)
Galectin-3, a Biomarker Linking Oxidative Stress and Inflammation With the Clinical Outcomes of Patients With Atherothrombosis
Julio Madrigal-Matute et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2014)
Functions of Galectin-3 and Its Role in Fibrotic Diseases
Liu-cheng Li et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2014)
Galectin-3 Mediates Aldosterone-Induced Vascular Fibrosis
Laurent Calvier et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2013)
The galectin-3/RAGE dyad modulates vascular osteogenesis in atherosclerosis
Stefano Menini et al.
CARDIOVASCULAR RESEARCH (2013)
Genetic and Pharmacological Inhibition of Galectin-3 Prevents Cardiac Remodeling by Interfering With Myocardial Fibrogenesis
Lili Yu et al.
CIRCULATION-HEART FAILURE (2013)
Prognostic Value of Changes in Galectin-3 Levels Over Time in Patients With Heart Failure Data From CORONA and COACH
A. Rogier van der Velde et al.
CIRCULATION-HEART FAILURE (2013)
Baseline and serial measurements of galectin-3 in patients with heart failure: relationship to prognosis and effect of treatment with valsartan in the Val-HeFT
Inder S. Anand et al.
EUROPEAN JOURNAL OF HEART FAILURE (2013)
Inhibition of galectin-3 reduces atherosclerosis in apolipoprotein E-deficient mice
Alison C. MacKinnon et al.
GLYCOBIOLOGY (2013)
Spatial and Temporal Expression, and Statin Responsiveness of Galectin-1 and Galectin-3 in Murine Atherosclerosis
Yong-Jin Lee et al.
KOREAN CIRCULATION JOURNAL (2013)
Regulation of Transforming Growth Factor-β1-driven Lung Fibrosis by Galectin-3
Alison C. MacKinnon et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
Altered expression of inflammation-related genes in human carotid atherosclerotic plaques
Maria Donata Di Taranto et al.
ATHEROSCLEROSIS (2012)
cAMP and Epac in the regulation of tissue fibrosis
Paul A. Insel et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Galectin-3 in Ambulatory Patients With Heart Failure Results From the HF-ACTION Study
G. Michael Felker et al.
CIRCULATION-HEART FAILURE (2012)
Galectin-3 predicts response to statin therapy in the Controlled Rosuvastatin Multinational Trial in Heart Failure (CORONA)
Lars Gullestad et al.
EUROPEAN HEART JOURNAL (2012)
Cellular and molecular mechanisms of intestinal fibrosis
Silvia Speca et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Galectin-3-A jack-of-all-trades in cancer
Anna U. Newlaczyl et al.
CANCER LETTERS (2011)
GALECTIN-3 PLASMA LEVELS AND CORONARY ARTERY DISEASE: A NEW POSSIBLE BIOMARKER OF ACUTE CORONARY SYNDROME
C. Falcone et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2011)
Macrophage migration inhibitory factor promotes cell death and aggravates neurologic deficits after experimental stroke
Ana R. Inacio et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2011)
C-reactive protein levels are associated with paraoxonase polymorphism L55M in patients undergoing cardiac SPECT imaging
Wanda Acampa et al.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2011)
Galectin-3: A Novel Blood Test for the Evaluation and Management of Patients With Heart Failure
Peter A. McCullough et al.
REVIEWS IN CARDIOVASCULAR MEDICINE (2011)
Identification and functional characterization of LDLR mutations in familial hypercholesterolemia patients from Southern Italy
Maria Romano et al.
ATHEROSCLEROSIS (2010)
Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study
Dirk J. A. Lok et al.
CLINICAL RESEARCH IN CARDIOLOGY (2010)
N-acetyl-seryl-aspartyl-lysyl-proline prevents cardiac remodeling and dysfunction induced by galectin-3, a mammalian adhesion/growth-regulatory lectin
Yun-He Liu et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2009)
Accelerated Lipid-Induced Atherogenesis in Galectin-3-Deficient Mice Role of Lipoxidation via Receptor-Mediated Mechanisms
Carla Iacobini et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Galectin-3: a novel mediator of heart failure development and progression
Rudolf A. de Boer et al.
EUROPEAN JOURNAL OF HEART FAILURE (2009)
Galectin-3 functions as an opsonin and enhances the macrophage clearance of apoptotic neutrophils
Anna Karlsson et al.
GLYCOBIOLOGY (2009)
Galectin-3 gene inactivation reduces atherosclerotic lesions and adventitial inflammation in ApoE-deficient mice
Maurice Nachtigal et al.
AMERICAN JOURNAL OF PATHOLOGY (2008)
Decreased paraoxonase-2 expression in human carotids during the progression of atherosclerosis
Giuliana Fortunato et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Galectin-glycan lattices regulate cell-surface glycoprotein organization and signalling
Omai B. Garner et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2008)
Expression and immunohistochemical localization of galectin-3 in various-mouse tissues
Heechul Kim et al.
CELL BIOLOGY INTERNATIONAL (2007)
Polymorphisms and the expression of genes encoding enzymes involved in cardiovascular diseases
Giuliana Fortunato et al.
CLINICA CHIMICA ACTA (2007)
Complex N-glycan number and degree of branching cooperate to regulate cell proliferation and differentiation
Ken S. Lau et al.
CELL (2007)
Galectin-3:: An open-ended story
J Dumic et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2006)
Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction
UC Sharma et al.
CIRCULATION (2004)
Clusters, bundles, arrays and lattices: novel mechanisms for lectin-saccharide-mediated cellular interactions
CF Brewer et al.
CURRENT OPINION IN STRUCTURAL BIOLOGY (2002)
Intracellular functions of galectins
FT Liu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2002)
Galectins and their ligands: amplifiers, silencers or tuners of the inflammatory response?
GA Rabinovich et al.
TRENDS IN IMMUNOLOGY (2002)
Association of galectin-1 and galectin-3 with Gemin4 in complexes containing the SMN protein
JW Park et al.
NUCLEIC ACIDS RESEARCH (2001)
Phosphorylation of the β-galactoside-binding protein galectin-3 modulates binding to its ligands
N Mazurek et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Interaction of a novel cysteine and histidine-rich cytoplasmic protein with galectin-3 in a carbohydrate-independent manner
RP Menon et al.
FEBS LETTERS (2000)
Share Paper
